Primary headache drug treatment in emergency departments in Australia and New Zealand
File version
Version of Record (VoR)
Author(s)
Kelly, Anne-Maree
Kinnear, Frances
Keijzers, Gerben
Kamona, Sinan
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
Abstract
Treating acute headache begins at home and continues, if necessary, in the emergency department (ED). Drug treatment is heterogenous,1 and understanding the determinants of prescribing could help appropriate medication choices. We therefore assessed the predictors of prescribing in Australian and New Zealand EDs for people with primary headache.
Journal Title
Medical Journal of Australia
Conference Title
Book Title
Edition
Volume
217
Issue
7
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2022 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Item Access Status
Note
Access the data
Related item(s)
Subject
Clinical sciences
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
Headache
Persistent link to this record
Citation
Chu, K; Kelly, A-M; Kinnear, F; Keijzers, G; Kamona, S, Primary headache drug treatment in emergency departments in Australia and New Zealand, Medical Journal of Australia, 2022, 217 (7), pp. 366-367